Trials / Unknown
UnknownNCT03775018
TAP Blockade for Pain Control in One-Anastomosis Gastric Bypass
Transversus Abdominis Plane (TAP) Blockade as Multimodal Analgesia for Pain Control in One-Anastomosis Gastric Bypass (OAGB)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Hospital General Universitario Elche · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients will be randomized into 2 groups: * TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia * IV: Patients receiving only intravenous Acetaminophen analgesia Postoperative pain 24 hours after surgery will be evaluated.
Detailed description
Patients will be randomized into 2 groups: * TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia (1g/6h) * IV: Patients receiving only intravenous Acetaminophen analgesia (1g/6h) Postoperative pain 24 hours after surgery will be evaluated, by a Visual Analogic Scale (VAS), ranging from 0 to 100mm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transversus abdominis plane blockade | Patients will undergo Transversus abdominis plane blockade with Bupivacaine 0.25% 30ml, applied in the plane between the internal oblique muscle and the trasnversus abdominis. The injection will be performed laterally to the port-sites, bilaterally at the same levels. |
| DRUG | Intravenous analgesia | Acetaminophen 1g/6h iv will be administered |
Timeline
- Start date
- 2018-12-13
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2018-12-13
- Last updated
- 2018-12-13
Source: ClinicalTrials.gov record NCT03775018. Inclusion in this directory is not an endorsement.